Skip to main content
. 2025 Jan 6;25:22. doi: 10.1186/s12879-024-10396-y

Table 3.

Clinical characteristics and detailed information of the blood culture results of patients who had positive or negative ddPCR results

All patients (n = 81) Patients with positive ddPCR results (n = 67) Patients with negative ddPCR results (n = 14) P value
Age (years), median (IQR) 74 (66–82) 75 (60–82) 70 (56–79) 0.14
Male, n (%) 46 (56.8) 38 (56.7) 8 (57.1) 0.97
Primary site of BSI
 Abdominal infection, n (%) 42 (51.9) 38 (56.7) 4 (28.6) 0.078
 Bile duct infection, n (%) 34 (42.0) 30 (44.8) 4 (28.6) 0.37
 Intestinal perforation, n (%) 5 (6.2) 5 (7.5) 0 (0) 0.58
 Urinary tract infection, n (%) 33(40.1) 24 (35.8) 8 (57.1) 0.14
 Others, n (%) 6 (7.4) 5 (7.5) 2 (14.3) 0.60
BSI caused by ESBL-producing E. coli, n (%) 19 (23.5) 15 (22.4) 4 (28.6) 0.73
Septic shock, n (%) 17 (21.0) 17 (25.4) 0(0) 0.034
28-day mortality, n (%) 8 (9.9) 8 (11.9) 0(0) 0.34
Blood culture
 TTP (h), median (IQR) 9.1 (8.4–10.5) 8.8 (8.3–10.1) 10.7 (9.9–12.5) < 0.001
 Positive for two sets of blood culture, n (%) 65 (80.2) 60 (89.6) 5 (35.1) < 0.001
No. of positive bottle of two sets of blood culture
 4 bottles, n (%) 50 (61.7) 48 (71.6) 2 (14.3) < 0.001
 3 bottles, n (%) 10 (12.5) 7 (10.5) 3 (21.4) 0.37
 2 bottles, n (%) 10 (12.5) 10 (14.3) 0 (0) 0.20
 2 bottles of different sets, n (%) 5 (6.3) 5 (7.5) 0 (0) 0.58
 1 bottle, n (%) 11 (13.8) 2 (3.0) 9 (64.3) < 0.001

ESBL, extended-spectrum β-lactamase IQR, interquartile range; TTP, Time-to-positivity; ESBL, Extended-Spectrum β-Lactamase